This section has been created to gather information and resources during the COVID-19 (coronavirus) outbreak. MPE wants to make sure you have access to the latest information regarding COVID-19 and how it affects myeloma patients and their treatments.
COVID-19 vaccines for myeloma patients: what you need to know
Myeloma Patients Europe (MPE) held the webinar “COVID-19 vaccines for myeloma patients: what you need to know” on Thursday, 29 April, to review the most recent updates on the approved COVID-19 vaccines in Europe and how they affect myeloma and AL amyloidosis patients.
The talk was given by Dr Anna Sureda, Head of the Hematology Department, Instituto Catalán de oncología (ICO), in Spain. Watch the recording here.